Related Experiment Videos
The macrophage electrophoretic mobility test: Results on carcinoma of the colon and rectum
Abstract:
The macrophage electrophoretic mobility (MEM) test was performed on guinea-pig macrophages treated with the interaction products of encephalitogenic protein and peripheral lymphocytes from 44 patients with colorectal cancer and 33 "healthy" controls. In 54/60 tests involving patients, statistically significant reductions in electrophoretic mobilities were observed, compared with 12/33 in controls. Our overall results on the reductions in macrophage mobilities by lymphocyte products are in accord with the work of some other workers, but not all. In contrast to many other studies, the standard procedures used here to express the results should permit an exchange of data on an international basis and allow a more rapid, general appraisal of the MEM test.
Insights
The macrophage electrophoretic mobility (MEM) test showed reduced cell movement in colorectal cancer patients. This diagnostic test may offer a new way to detect cancer by analyzing immune cell responses.
Area of Science:
- Immunology
- Oncology
- Biomedical diagnostics
Background:
- The macrophage electrophoretic mobility (MEM) test analyzes immune cell function.
- Previous studies have explored its potential in cancer diagnostics with varying results.
Purpose of the Study:
- To evaluate the efficacy of the MEM test in detecting colorectal cancer.
- To standardize MEM test procedures for international data exchange and rapid appraisal.
Main Methods:
- Guinea-pig macrophages were treated with interaction products of encephalitogenic protein and lymphocytes.
- Peripheral lymphocytes were obtained from 44 colorectal cancer patients and 33 healthy controls.
- Electrophoretic mobility of macrophages was measured.
Main Results:
- Statistically significant reductions in macrophage electrophoretic mobility were observed in 54 out of 60 tests involving cancer patients.
- Reduced mobility was observed in 12 out of 33 tests involving healthy controls.
- Results align with some previous findings but show discrepancies with others.
Conclusions:
- The MEM test demonstrates potential as a diagnostic tool for colorectal cancer.
- Standardized procedures enhance the test's utility for international collaboration and widespread application.
- Further validation is warranted to confirm its diagnostic accuracy and clinical utility.